Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Petrichor ESG Innovations, founded in 2018, is a venture capital firm based in New York, NY. The firm focuses on supporting healthcare managers and businesses through customized investment structures. Their platform encompasses company formation and late-stage growth opportunities, emphasizing a long-term and strategic approach to investment.
The firm has a team of 12 professionals with expertise in biopharmaceuticals and medical technologies. Petrichor ESG Innovations aims to transform the healthcare landscape by investing in innovative solutions that enhance patient care and operational efficiency. Their commitment to healthcare innovation is reflected in their investment strategies and the expertise of their team.
Petrichor ESG Innovations invests in innovative biopharmaceuticals, medical technologies, and services that aim to transform the healthcare landscape. Their investment strategy spans various stages, including pre-seed, seed, seed+, Series A, Series B, Series C, and growth equity. This broad stage focus allows them to support companies at different points in their development.
The firm emphasizes structured investments that facilitate the development and commercial growth of healthcare businesses. Petrichor targets companies that demonstrate potential for significant impact in the healthcare sector, particularly those that align with their expertise in biopharmaceuticals and medical technologies.
Petrichor ESG Innovations has not publicly disclosed specific portfolio companies. However, their investment focus includes innovative biopharmaceuticals and medical technologies. The firm is known for supporting companies that are developing transformative healthcare solutions.
While no notable exits or current portfolio companies are listed, Petrichor's emphasis on structured investments suggests a commitment to nurturing companies through various growth stages. Their expertise in healthcare positions them to identify and invest in promising ventures within the sector.
Tadd Wessel - Founder and Managing Partner. Tadd has extensive experience in healthcare investments and has led numerous successful funding rounds.
Patrick Lally - Partner. Patrick brings a wealth of knowledge in biopharmaceuticals and has been instrumental in shaping the firm's investment strategy.
Michael Beecham - Partner. Michael specializes in medical technologies and has a strong track record in identifying promising healthcare ventures.
Hayden Fownes - Vice President. Hayden focuses on deal sourcing and due diligence, contributing to the firm's investment decisions.
Justin Lish - Vice President. Justin has a background in healthcare consulting and supports portfolio companies in their growth strategies.
Lucy Burke - Senior Associate. Lucy assists in research and analysis, helping to identify investment opportunities.
Samuel Hall, PhD - Founder, Managing Partner Scion. Samuel has a PhD and extensive experience in healthcare innovation.
Aaron Kantoff - Founder, Managing Partner Scion. Aaron has a strong background in venture capital and healthcare investments.
Andreas Loew, PhD - Partner. Andreas specializes in biopharmaceuticals and has a PhD in a relevant field.
Wiliam Chour, MD, PhD - Associate. Wiliam combines medical expertise with investment acumen.
Samuel Hendel, PhD - Associate. Samuel has a strong research background in healthcare.
Elliot Warner, PhD - Associate. Elliot focuses on healthcare technology investments.
David Katona - Head of Business Development & Investor Relations. David manages relationships with investors and portfolio companies.
Eidul Hossein - Director of Finance. Eidul oversees financial operations and reporting.
MaryAnn Lungariello - Executive Assistant. MaryAnn supports the team in administrative functions.
To pitch to Petrichor ESG Innovations, founders should send an email to info@petrichorcap.com. A well-structured pitch deck is essential, detailing the business model, market opportunity, and team qualifications. Response times may vary, so patience is advised after submission.
No recent public activity beyond the website content has been detected for Petrichor ESG Innovations. The firm actively promotes its focus on healthcare innovation through its website, detailing its investment strategies and areas of expertise.
What are Petrichor ESG Innovations' investment criteria?
Petrichor focuses on innovative biopharmaceuticals and medical technologies. They invest across various stages, from pre-seed to growth equity, and seek companies that demonstrate potential for significant impact in the healthcare sector.
How can founders pitch to Petrichor ESG Innovations?
Founders can reach out via email at info@petrichorcap.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team qualifications.
What makes Petrichor ESG Innovations different from other venture capital firms?
Petrichor emphasizes structured investments tailored to the unique needs of healthcare businesses. Their focus on long-term growth and expertise in biopharmaceuticals and medical technologies sets them apart.
What is the geographic scope of Petrichor ESG Innovations?
The firm primarily operates within the United States, focusing on healthcare innovation and investment opportunities in the U.S. market.
What type of post-investment involvement does Petrichor ESG Innovations have?
Petrichor typically engages with portfolio companies to provide support in strategic growth and development, leveraging their expertise in healthcare.
What is the typical check size for investments made by Petrichor ESG Innovations?
While specific check sizes are not disclosed, Petrichor invests across various stages, indicating a flexible approach to funding based on the needs of the business.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.